Skip to Main Content

Author Details

Jesus E Juarez
University of California Los Angeles
2015
16
9
PMIDPaper TitleJournal TitlePublished Year
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
34049980aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in <sup>18</sup>F-DCFPyL Images of Veterans with Prostate Cancer.J Nucl Med2022
35644708Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy.Clin Oncol (R Coll Radiol)2022
33602654Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.Eur Urol Oncol2022
34990726Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.Radiother Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34400799Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.Prostate Cancer Prostatic Dis2022
33035622Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.Radiother Oncol2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34585025Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.Adv Radiat Oncol2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
32373529Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer.Front Oncol2020
35117811Acute toxicities after extremely hypofractionated radiotherapy for prostate cancer: lessons from HYPO-RT-PC and PACE-B.Transl Cancer Res2020
28366573Patterns of Care for Elderly Patients With Locally Advanced Head and Neck Cancer.Int J Radiat Oncol Biol Phys2017
25990957ERK reinforces actin polymerization to power persistent edge protrusion during motility.Sci Signal2015
  • 1 - 16 of 16

Recommended Authors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 17
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 54
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 21
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Stanford University
Career Start Year 2012
Number of shared co-authors 9
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 44
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 24
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 16
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 4
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 6
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 21
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 15
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 13
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 24
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 29
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 38
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 2
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 11
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 29
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 7
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 16
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 30
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 69
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 39
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 48
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 54

Collaborators

University of California los angeles
Co-authored papers 12
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 11
University of California los angeles
Co-authored papers 10
David Geffen School of Medicine, University of California los angeles
Co-authored papers 8
university of california los angeles Medical Center
Co-authored papers 8
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
university of california los angeles Medical Center
Co-authored papers 7
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 7
David Geffen School of Medicine at university of california los angeles
Co-authored papers 6
David Geffen School of Medicine at University of California los angeles
Co-authored papers 6
University of Washington
Co-authored papers 5
University of Maryland School of Medicine
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Oslo University Hospital
Co-authored papers 5
Cleveland Clinic
Co-authored papers 4
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Ascension Providence Hospital
Co-authored papers 4
University of Michigan ann arbor
Co-authored papers 4
Johns Hopkins University
Co-authored papers 4
Fox Chase Cancer Center
Co-authored papers 4
University of California los angeles
Co-authored papers 4
Oslo University Hospital
Co-authored papers 4
Cleveland Clinic
Co-authored papers 4
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 4